IBO Earnings

Quarterly EPS
$-29.68
Q4 2024
$-1.39
Q1 2025
$-14.89
Q2 2025
$-1.52
Q3 2025
$0.74
Q4 2025
$-0.25
Q1 2026
$-0.13
Q2 2026
$-0.08
Q3 2026
Latest Revenue21.0K
Latest Net Income-644000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q3 2026-$0.0821.0K-644000+16.7%+94.7%
Q2 2026-$0.133.0K-700000-57.1%+99.1%
Q1 2026-$0.257.0K-2284000—+82.0%
Q4 2025$0.747.0K5.2M—+102.5%
Q3 2025-$1.5218.0K-1475000—-132.5%
Q2 2025-$14.897.0K-14352000——
Q1 2025-$1.390-1278000——
Q4 2024-$29.680-27133000——
Q3 2024$4.6704.2M——
Impact BioMedical (IBO) — Earnings